ALX Oncology (NASDAQ: ALXO)
$0.60
(3.4%)
$0.02
Price as of April 24, 2025, 3:55 p.m. ET
Key Data Points
Current Price
$0.60
Daily Change
(3.4%) $0.02
Day's Range
$0.59 - $0.63
Previous Close
$0.60
Open
$0.60
Beta
1.38
Volume
362,549
Average Volume
856,679
Sector
Market Cap
$32M
Market Cap / Employee
$401MM
52wk Range
$0.46 - $17.83
Revenue
-
Gross Margin
0%
Dividend Yield
N/A
EPS
-$2.61
CAPs Rating
-
Industry
Biotechnology
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
ALX Oncology Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
ALX Oncology Company Info
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
News & Analysis
Featured Article
Why ALX Oncology Stock Is Skyrocketing Today
Investors are cheering the immuno-oncology company's latest clinical trial results.
Keith Speights | Oct 3, 2023
Featured Article
Why Shares of ALX Oncology Holdings Fell Thursday
Several company executives sold shares of the stock.
Jim Halley | Jul 6, 2023
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.